PerpEquitiesTop analysts on stock perps · Analyst
Alexandria Hammond (Wolfe Research): analyst track record on stock perps
Alexandria Hammond of Wolfe Research on companies with stock perpetual futures: star rating, success rate, price-target accuracy, current calls and the measured perp reaction after each rating.
Stars0.1★
Success42%
Excess return-25.5%
rank#12,230
Ratings33
ratings on stock perps44
Track record
TipRanks data via FMP| 12 months | 3 years | |
|---|---|---|
| Ratings | 23 | 61 |
| Stock | 17 | 25 |
| Buy / hold / sell | 14 / 4 / 5 | 34 / 16 / 11 |
| Upgrades / downgrades / initiations | 6 / 3 / 0 | 6 / 3 / 13 |
| Price targets hit / missed | 11 / 8 (58%) | 32 / 19 (63%) |
| Avg. return after a rating (TipRanks) | +66.8% | +58.6% |
| Best / worst call | +703.7% / -28.2% | +703.7% / -49.6% |
After buy calls: median 21-day move -0.2% · vs S&P 500 -1.1% · targets hit within a year 71% (n = 40)
Current calls on stock perps
| Stock | Call | Target | vs last close | Date |
|---|---|---|---|---|
| $MRK Merck & Co., Inc. | Buy · Maintained | $180 | +24.4% | Aug 25, 2026 |
| $MRNA Moderna, Inc. | Hold · Upgraded | – | – | Aug 25, 2026 |
| $ABBV AbbVie Inc. | Buy · Upgraded | $300 | +17.7% | Aug 13, 2026 |
| $BIIB Biogen Inc. | Buy · Upgraded | $300 | +39.3% | Aug 13, 2026 |
| $LLY Eli Lilly and Company | Buy · Maintained | $1,350 | +20.2% | May 21, 2026 |
| $REGN Regeneron Pharmaceuticals, Inc. | Buy · Reiterated | $860 | +8.4% | May 18, 2026 |
| $PFE Pfizer Inc. | Sell · Reiterated | $26.00 | -6.0% | May 13, 2026 |
Recent ratings
- Aug 25, 2026 $MRK: Maintained · Buy · $180 · article
- Aug 25, 2026 $MRNA: Upgraded · Hold · article
- Aug 13, 2026 $BIIB: Upgraded · Buy · $300 · article
- Aug 13, 2026 $ABBV: Upgraded · Buy · $300 · article
- May 21, 2026 $LLY: Maintained · Buy · $1,350 · article
- May 18, 2026 $REGN: Reiterated · Buy · $860 · article
- May 13, 2026 $PFE: Reiterated · Sell · $26.00 · article
- Jan 8, 2026 $MRK: Upgraded · Buy · $135 · article
- Jan 8, 2026 $ABBV: Downgraded · Hold · article
- Nov 20, 2025 $MRNA: Reiterated · Sell · $17.00 · article
- Oct 17, 2025 $MRNA: Maintained · Sell · $20.00 · article
- Oct 15, 2025 $JNJ: Maintained · Buy · $225 · article
- Oct 6, 2025 $JNJ: Maintained · Buy · $200 · article
- Sep 22, 2025 $PFE: Reiterated · Sell · $25.00 · article
- Sep 3, 2025 $JNJ: Maintained · Buy · $195 · article
- Aug 8, 2025 $LLY: Maintained · Buy · $825 · article
- Jul 10, 2025 $JNJ: Reiterated · Buy · $175 · article
- Feb 14, 2025 $MRNA: Reiterated · Sell · $25.00 · article
- Dec 10, 2024 $JNJ: Resumed · Hold · $166 · article
- Dec 10, 2024 $GILD: Resumed · Buy · $109 · article
Alexandria Hammond0.1★ · 42% success · -25.5% excess return · TipRanks data via FMP · Source headlines via TheFly/StreetInsider (FMP). Reaction = venue-median perp move after our detection — an observation, not investment advice.